Travel-Related Venous Thrombosis: Results from a Large Population-Based Case Control Study (MEGA Study)

Por Cannegieter, Suzanne C, Doggen, Carine J. M, van Houwelingen, Hans C, Rosendaal, Frits R
Publicado em 2006

Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis

Por Meltzer, Mirjam E, Lisman, Ton, Doggen, Carine J. M, de Groot, Philip G, Rosendaal, Frits R
Publicado em 2008

Trauma team activation varies across Dutch emergency departments: a national survey

Por Egberink, Rolf E., Otten, Harm-Jan, IJzerman, Maarten J., van Vugt, Arie B., Doggen, Carine J. M.
Publicado no Scand J Trauma Resusc Emerg Med (2015)

Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men

Por Meltzer, Mirjam E., Doggen, Carine J.M., de Groot, Philip G., Meijers, Joost C.M., Rosendaal, Frits R., Lisman, Ton
Publicado em 2009

Prehospital paths and hospital arrival time of patients with acute coronary syndrome or stroke, a prospective observational study

Por Doggen, Carine J. M., Zwerink, Marlies, Droste, Hanneke M., Brouwers, Paul J. A. M., van Houwelingen, Gert K., van Eenennaam, Fred L., Egberink, Rolf E.
Publicado no BMC Emerg Med (2016)

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial

Por van Houwelingen, K. Gert, van der Heijden, Liefke C., Lam, Ming Kai, Kok, Marlies M., Löwik, Marije M., Louwerenburg, J. W., Linssen, Gerard C. M., IJzerman, Maarten J., Doggen, Carine J. M., von Birgelen, Clemens
Publicado no Heart Vessels (2016)

F9 Malmö, factor IX and deep vein thrombosis

Por Bezemer, Irene D., Arellano, Andre R., Tong, Carmen H., Rowland, Charles M., Ireland, Helen A., Bauer, Kenneth A., Catanese, Joseph, Reitsma, Pieter H., Doggen, Carine J.M., Devlin, James J., Rosendaal, Frits R., Bare, Lance A.
Publicado em 2009

Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial

Por van der Heijden, Liefke C., Kok, Marlies M., Lam, Ming Kai, Danse, Peter W., Schramm, Alexander R., Jessurun, Gillian A. J., Tjon Joe Gin, R. Melvyn, van Houwelingen, K. Gert, Hautvast, Raymond W. M., Linssen, Gerard C. M., Sen, Hanim, Löwik, Marije M., IJzerman, Maarten J., Doggen, Carine J. M., von Birgelen, Clemens
Publicado no Clin Res Cardiol (2015)